A randomised study of a Nurse-led Intervention for Less Chronic Heart Failure: The NIL-CHF Study

Not Applicable

Completed

• Conditions: Cardiovascular disease; Cardiovascular - Diseases of the vasculature and circulation including the lymphatic system

• Registration Number: ACTRN12608000022369
• Lead Sponsor: Baker IDI Heart and Diabetes Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-01-16
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 624

Inclusion Criteria

All elective and emergency patients admitted to the Alfred Hospital, Melbourne. Eligible for study if (i) discharged to home (ii) have a diagnosis of one of the common forms of cardiovascular disease or being actively treated for either of the 2 most common heart failure antecedents other than coronary heart disease (eg diabetes, metabolic syndrome or hypertension)

Exclusion Criteria

Diagnosed with congenital condition, have surgically repairable or significant valvular disease, have a terminal malignancy, live beyond a 45km radius from the hospital or have an acute coronary event (eg acute myocardial infarction) within previous 30 days.
Further exclusion of those randomised subjects who experience a HF-related hospitalisation prior to the 30-35 day advanced clinical assessment.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Event-free from all cause mortality or chronic heart failure related hospitalisation[Interventions will be performed following discharge from hospital (7 to 14 days after discharge) with one and two year annual follow-up clinic assessments and a final assessment at 3 years for all patients. Each visit will be 1 to 1.5 hours duration.]